No Data
TuHURA Biosciences | 8-K: TuHURA Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides a Corporate Update
Express News | TuHURA Biosciences Q4 EPS $(0.13) Beats $(0.14) Estimate
TuHURA Biosciences Had Cash and Cash Equivalents of $3.6M at Dec 31 >HURA
Express News | Tuhura Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides a Corporate Update
TuHURA Biosciences | 10-K: FY2025 Annual Report
These 16 Stocks Are a Short Seller's Dream - Likely Losers No Matter What the Market Does
carlton Griffiths OP :![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined")
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined")